Rescheduling Cannabis: A Scientific Imperative

S3 Collective News

Let's Get Science on the Record

On January 30th, the S3 Collective hosted an educational webinar aimed at shedding light on the DEA’s potential rescheduling of cannabis to Schedule III, emphasizing its medical and scientific implications.

If you missed it, it’s now available on-demand for those who couldn’t attend live.

Alena Rodriguez, Technical Director for the S3 Collective, led the session, joined by an expert panel:

Jahan Marcu, PhD, of Marcu Enterprises,
Andrew Kline, Firmwide Cannabis Co-Chair at Perkins Coie LLP,
Shane Pennington, Partner at Porter Wright Morris & Arthur LLP, and
David Vaillencourt, CEO of The GMP Collective and Board Chair of the S3 Collective.

Key Highlights of the Webinar:

  • Introduction to the S3 Collective and its mission.
  • Overview of the DEA’s possible cannabis rescheduling process.
  • Strategy for incorporating scientific research and evidence-based data into the public comment process.
  • Opportunities for YOU to get involved and support this critical initiative.

We invite you to watch the webinar below and join us in this historical moment.

Looking for more resources on rescheduling?

Here are some of our top recommendations to read if you are seeking more information on the Rescheduling process and it’s potential impacts:

  1. Why Fears about Biden’s Marijuana Moves are Overblown (Mona Zhang, Politico)
  2. Feds Release 250+ Pages of Redacted Documents on Marijuana Rescheduling Recommendation, Detailing Cannabis’s Medical Value (Ben Adlin, Marijuana Moment)
  3. Feds Will Release Marijuana Rescheduling Memo And Related Documents ‘In Their Entirety’ In Response To Lawsuit (Ben Adlin, Marijuana Moment)
  4. The Dirtiest Little Secrets About Rescheduling (Matt Zorn, On Drugs)
  5. Even DIRTIER Secrets on Rescheduling (Matt Zorn, On Drugs)
  6. Digging Into HHS’s Latest FOIA Release (Shane Pennington, On Drugs)
  7. Latest Filing in Marijuana Rescheduling FOIA Case (Shane Pennington and Matt Zorn, On Drugs)
  8. DEA Tells Congress It Has ‘Final Authority’ On Marijuana, Regardless Of Health Agency’s Schedule III Recommendation (Klye Jaeger, Marijuana Moment)

in News
Welcoming Scheril Murray Powell to the Board of Directors
S3 Collective News